Bank of America
EW icon

Bank of America’s Edwards Lifesciences EW Stock Holding History

Bank of America’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-152,200
Closed -$11.9M – 8420
2025
Q2 		$11.9M Buy
152,200
+107,200
+238% +$7.99M ﹤0.01% 3074
2025
Q1 		$3.26M Sell
45,000
-460,000
-91% -$32.9M ﹤0.01% 4234
2024
Q4 		$37.4M Buy
505,000
+494,800
+4,851% +$34.6M ﹤0.01% 1745
2024
Q3 		$673K Buy
10,200
+3,600
+55% +$262K ﹤0.01% 5300
2024
Q2 		$610K Sell
6,600
-59,500
-90% -$5.27M ﹤0.01% 5222
2024
Q1 		$6.32M Sell
66,100
-88,900
-57% -$7.47M ﹤0.01% 3412
2023
Q4 		$11.8M Buy
+155,000
New +$10.8M ﹤0.01% 2702
2022
Q1 		– Sell
-7,000
Closed -$907K – 8403
2021
Q4 		$907K Sell
7,000
-66,700
-91% -$7.78M ﹤0.01% 5383
2021
Q3 		$8.34M Sell
73,700
-31,300
-30% -$3.57M ﹤0.01% 3043
2021
Q2 		$10.9M Buy
105,000
+91,000
+650% +$8.58M ﹤0.01% 2753
2021
Q1 		$1.17M Buy
14,000
+7,000
+100% +$592K ﹤0.01% 4702
2020
Q4 		$639K Buy
+7,000
New +$581K ﹤0.01% 4836
2020
Q1 		– Sell
-9,600
Closed -$747K – 6954
2019
Q4 		$747K Sell
9,600
-609,000
-98% -$47.6M ﹤0.01% 4704
2019
Q3 		$45.3M Buy
618,600
+609,000
+6,344% +$42.8M 0.01% 1199
2019
Q2 		$591K Buy
+9,600
New +$580K ﹤0.01% 4943
2017
Q2 		– Sell
-120,000
Closed -$3.76M – 6997
2017
Q1 		$3.76M Buy
120,000
+24,000
+25% +$751K ﹤0.01% 3303
2016
Q4 		$3M Buy
+96,000
New +$3.11M ﹤0.01% 3414
2016
Q2 		– Sell
-157,500
Closed -$4.63M – 7182
2016
Q1 		$4.63M Buy
+157,500
New +$4.35M ﹤0.01% 2846
2015
Q1 		– Sell
-22,200
Closed -$471K – 7190
2014
Q4 		$471K Buy
22,200
+13,200
+147% +$265K ﹤0.01% 4668
2014
Q3 		$153K Buy
9,000
+3,000
+50% +$47.4K ﹤0.01% 5639
2014
Q2 		$86K Sell
6,000
-3,000
-33% -$40.7K ﹤0.01% 6251
2014
Q1 		$111K Sell
9,000
-4,200
-32% -$48.5K ﹤0.01% 5914
2013
Q4 		$145K Sell
13,200
-16,800
-56% -$189K ﹤0.01% 5857
2013
Q3 		$348K Buy
+30,000
New +$351K ﹤0.01% 4947

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America's EW Position: Q1 2026 in Review

Bank of America increased its Edwards Lifesciences (EW) stake by 132% in Q1 2026, buying an estimated $182M and bringing the position to 3,883,419 shares worth $311M. The position accounts for 0.02% of the portfolio, ranked #553.

Bank of America first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $690M in Q4 2021. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Bank of America held 3,883,419 shares of Edwards Lifesciences worth $311M as of Q1 2026.
  • Bank of America bought 2,212,208 Edwards Lifesciences shares in Q1 2026, an estimated $182M.
  • Edwards Lifesciences made up 0.02% of Bank of America's portfolio in Q1 2026, its #553 holding.
  • Bank of America first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Edwards Lifesciences position peaked at $690M in Q4 2021.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.